andiolol hydrochloride for prevention of postoperative atrial fibrillation after esophageal cancer surgery: The double-blind, randomized, placebo-controlled trial
Phase 3
- Conditions
- Esophageal cancer
- Registration Number
- JPRN-UMIN000010648
- Lead Sponsor
- Second Department of Surgery, Wakayama Medical University, School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
1)Past of arrhythmia 2)Second -or third-degree AV block 3)Sinus bradycardia at rest < 50/min 4)With pacemaker 5)Clinical heart failure 6)Doctor's decision not to register to this regimen
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Incidence of postoperative atrial fibrillation
- Secondary Outcome Measures
Name Time Method Incidence of postoperative complications Blood pressure, heart rate Inflammatory index: WBC, CRP, IL-6, HMGB-1